Pharmaceuticals
-
Plasma jabs no use for Achilles pain
A new study has found no benefit for treatment with platelet rich plasma injections for Achilles tendinopathy. Read more
-
Flu vaccines, HIV risks and double infection reported to conference
People vaccinated against flu may have enjoyed some protection against the worst effects of COVID-19, a major European conference has heard. Read more
-
Children’s risk of developing severe COVID-19 ‘very low’
The risk of severe illness and death from COVID-19 is extremely low in children and teenagers, according to the most comprehensive analyses of public health data yet. Read more
-
Aspirin reduces heart attack risk in pneumonia patients
Aspirin can reduce the risk of myocardial infarction and stroke in patients with pneumonia, a new study reveals today. Read more
-
Back pain drugs and orthopaedic procedures questioned
Prescribing muscle relaxant drugs for low back pain gives only short-term relief and there is an increased risk of side-effects, new analysis claims today. Read more
-
Immune drug brings overall benefit for COVID-19
Mortality among patients hospitalised with COVID-19 is reduced when they receive treatment with Interleukin-6 antagonists, according to the findings of a major analysis that has led to a change to global guidelines. Read more
-
Aspirin could reduce metastatic spread
Aspirin could cut the risk of death in some cancer patients by up to 20%, according to a new analysis. Read more
-
Novel HIV vaccine trial starts at Oxford
A phase I trial into a novel HIV vaccine has begun in the UK. Read more
-
New warning on Africa pandemic
Africa is suffering from a “surging” third wave of the pandemic caused by several new variants, the World Health Organisation warned yesterday. Read more
-
Novel pancreatic cancer biomarker found
A new biomarker for pancreatic cancer has been identified, raising hopes of earlier diagnosis, British researchers have announced. Read more
